Flag­ship plants next bet on chron­ic dis­eases with ex-An­ces­try CEO at the helm

Af­ter run­ning Google’s Amer­i­c­as di­vi­sion, steer­ing the ship at toy­mak­er Mat­tel and sell­ing An­ces­try.com for $5 bil­lion, Mar­go Geor­giadis is now lead­ing the lat­est bet by Flag­ship Pi­o­neer­ing, which de­buted Tues­day with $50 mil­lion.

Mon­tai Health broke stealth af­ter three years in the works at Noubar Afeyan’s biotech in­cu­ba­tor, which has spawned the likes of Mod­er­na and a long list of oth­er drug de­vel­op­ers and agri­cul­tur­al tech star­tups. That now in­cludes a hunt for new chron­ic dis­ease treat­ments based on mol­e­cules al­ready con­sumed by hu­mans via foods, sup­ple­ments and herbal med­i­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER